View Single Post
Old 10-05-2012, 07:56 AM   #12
Ellie F
Senior Member
 
Join Date: Feb 2009
Posts: 1,526
Re: TDM-1 results reported @ ASCO annual mtg 2012 now in New England Journal of Medic

Hi all
If you think the FDA is bad then NICE ( or nasty) here in England is terrible! The bean counters still won't fund lapatinib and I suspect T-DM1 and pertuzumab will have a big struggle also. This is such a shame for all those that need it and causes huge frustration for our breast oncologists who effectively have their hands tied.
Ellie
Ellie F is offline   Reply With Quote